A single institution experience with palbociclib toxicity requiring dose modifications

December 8, 2017

A single institution experience with palbociclib toxicity requiring dose modifications

Published on 12/07/2017

previous post: Trust in doctors may color parents' perception of child’s cancer prognosis
next post: Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies